Characterization of Arrhythmia-induced Cardiomyopathy
Recruiting
Observational Study
Cardiomyopathy
Arrhythmia-induced Cardiomyopathy (AiCM)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,700 (estimated)
- Sponsor
- University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Prospective part
Inclusion Criteria:
* Diagnostic or suspicion of AiCM as presence of specified keyword in patient's file or as screened by colleagues of the internal medicine or cardiology clinics
* Signed study consent
Exclusion Criteria:
* Patient's active refusal of the general consent of th…
Contacts